Commentary on "Genome-wide meta-analysis identifies novel susceptibility loci for autoimmune hepatitis type 1"

Affiliations

Editorial

Victoria L Mulcahy et al. Hepatology. 2022 Sep.

. 2022 Sep;76(3):541-543.

doi: 10.1002/hep.32547. Epub 2022 May 27.

¹ Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK.

No abstract available

Comment on

Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1.
Li Y, Sun Y, Liu Y, Wang B, Li J, Wang H, Zhang H, Wang X, Han X, Lin Q, Zhou Y, Hu L, Song Y, Bao J, Gong L, Sun M, Yuan X, Zhang X, Lian M, Xiao X, Miao Q, Wang Q, Li KK, Du S, Ma A, Li Y, Xu J, Tang S, Shi J, Xu Y, Yang L, Zhang J, Huang Z, Zhou L, Cui Y, Seldin MF, Gershwin ME, Yan H, Zou Z, Zuo X, Tang R, Ma X; Chinese AIH Consortium. Li Y, et al. Hepatology. 2022 Sep;76(3):564-575. doi: 10.1002/hep.32417. Epub 2022 Jun 3. Hepatology. 2022. PMID: 35184318

1. Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72(2):671-722.
1. Dyson JK, Wong LL, Bigirumurame T, Hirschfield GM, Kendrick S, Oo YH, et al. Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom. Aliment Pharmacol Ther. 2018;48(9):951-60.
1. Li Y, Sun Y, Liu Y, Wang B, Li J, Wang H, et al. Genome-wide meta-analysis identifies novel susceptibility loci for autoimmune hepatitis type 1. Hepatology. 2022;76:564-75.
1. Hosseini A, Gharibi T, Marofi F, Babaloo Z, Baradaran B. CTLA-4: from mechanism to autoimmune therapy. Int Immunopharmacol. 2020;80:106221.
1. de Boer YS, van Gerven NMF, Zwiers A, Verwer BJ, van Hoek B, van Erpecum KJ, et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology. 2014;147(2):443-52.e5.